[Table_Title] 万联晨会 [Table_Summary] 概览 【市场回顾】周三 A 股全天震荡调整。截至收盘，上证综指跌 0.01%， 深证成指跌 0.64%，创业板指跌 0.55%；北证 50 跌 3.79%。两市成交 额 1,2813 亿元，创近 3 个月以来新低。大盘资金净流出超 655 亿元。 全天 4400 只股票下跌。板块方面，保险、银行、煤炭开采加工、零 售等行业及脑机接口、液冷服务器等概念涨幅较大。互联网电商、IT 服务、文化传媒、种植业等行业及民爆、培育钻石等概念跌幅居前。 【重要新闻】 【2025 年全国"两会"将于 3 月 5 日召开】十四届全国人大常委会第 十三次会议 25 日表决通过了关于召开十四届全国人大三次会议的决 定。根据决定，十四届全国人大三次会议将于 2025 年 3 月 5 日在北 京召开。决定建议十四届全国人大三次会议的议程是：审议政府工作 报告；审查 2024 年国民经济和社会发展计划执行情况与 2025 年国 民经济和社会发展计划草案的报告、2025 年国民经济和社会发展计 划草案；审查 2024 年中央和地方预算执行情况与 2025 年中央和地 方预 ...

Industry Investment Rating - The report gives a "Stronger than Market" rating to the retail pharmacy industry, indicating a positive outlook for the sector [4] Core Views - The retail pharmacy industry is expected to benefit from the trend of prescription outflow and the inclusion of retail pharmacies in outpatient统筹 management, which will drive market expansion [1][3] - Large chain pharmacies are better positioned to benefit from these trends due to their compliance,精细化管理, and stronger选品和服务能力 [1][7] - The industry is expected to see increased market concentration and连锁化率, with large chains gaining more market share [1][7] Industry Trends - The aging population and the increasing reliance on医保统筹 for慢性病用药需求 will drive the expansion of the院外市场 [1][7] - The integration of retail pharmacies into outpatient统筹 management will accelerate处方外流, benefiting large chain pharmacies [3][7] - The industry is expected to see a shift towards more合规运营 and精细化管理, with large chains having an advantage due to their stronger议价能力 and数字化赋能 [1][7] Financial Performance of Listed Companies - The revenue and store expansion of listed pharmacies are positively correlated, with益丰药房 and大参林 showing领先的收入规模和增速 [4][54] - The毛利率水平 of pharmacies with larger store and revenue scales is领先, with益丰药房 and老百姓 showing领先的销售毛利率水平 [2][55] - The运营效率 of pharmacies is influenced by factors such as应付账款周转天数 and库存周转天数, with大参林 showing领先的营运指标 [4][87] Key Companies - **益丰药房**: Focuses on expansion and精细化运营, with a leading position in the中南,华东, and华北 markets [133] - **大参林**: Deeply rooted in华南 and expanding nationwide, with the largest number of stores in the industry [134] - **老百姓**: A老牌连锁药店 with a全国布局, covering 18 provinces [138] - **一心堂**: The龙头 of云南省 retail pharmacies, with a strong presence in西南 and华南 regions [122] - **漱玉平民**: The龙头 of山东省 retail pharmacies, with a focus on直营连锁 and区域深耕 [124] - **健之佳**: Focuses on多元化布局, with a strong presence in云南 and西南 regions [140] - **华人健康**: Focuses on安徽 and华东 regions, with a strong presence in安徽省 [145] - **第一医药**: A老字号医药流通企业 in上海, with a批零一体 model [146] Investment Recommendations - The report recommends focusing on large chain pharmacies with strong professional服务能力,合规经营, and供应链优势, as they are expected to benefit from the长期利好趋势 in the industry [149]

[Table_AdressInfo] 万联证券股份有限公司 研究所 [Table_MeetReportDate] 2024 年 12 月 25 日 星期三 核心观点 | --- | --- | --- | |------------|----------------------|-------| | | 指数名称 收盘 涨跌幅 | % | | 上证指数 | 3,393.53 | 1.26% | | 深证成指 | 10,671.43 | 1.27% | | 沪深 300 | 3,983.69 | 1.27% | | 科创 50 | 1,014.02 | 1.54% | | 创业板指 | 2,213.55 | 1.17% | | 上证 50 | 2,702.28 | 1.16% | | 上证 180 | 8,732.37 | 1.19% | | 上证基金 | 6,925.90 | 1.04% | | 国债指数 | 222.26 | 0.00% | Email: yutx@wlzq.com.cn 万千财富，与您相连 [Table_MeetContent] 【市场回顾】周二，A 股三大股指震荡上行，上证指数收盘涨 1 ...

Core Insights - The report highlights the recent performance of the A-share market, with the Shanghai Composite Index closing at 3,368.07 points, down 0.06% [9] - The Shenzhen Component Index and the ChiNext Index also experienced slight declines of 0.02% and 0.18% respectively [9] - The total trading volume across both markets reached 1.53 trillion yuan, indicating active market participation despite the slight downturn [9] Market Review - The electronic, beauty care, and textile industries showed the largest gains, while the coal, steel, and oil & petrochemical sectors faced the most significant declines [9] - Concept indices such as ASIC chips, Pinduoduo collaborations, and e-commerce led the market, whereas state-owned coal and excavator concept indices saw the largest drops [9] - In the Hong Kong market, the Hang Seng Index closed down 0.16%, while the Hang Seng Technology Index saw a slight increase of 0.11% [9] - Internationally, U.S. indices collectively rose, while most European and Asia-Pacific indices experienced declines [9]

Core Views - The A-share market showed mixed performance with the Shanghai Composite Index down by 0.36%, while the Shenzhen Component Index and the ChiNext Index rose by 0.61% and 0.52% respectively. The total market turnover reached 1.4647 trillion yuan, an increase of 89.4 billion yuan from the previous day, with over 2400 stocks rising. Key sectors that performed well included liquid cooling servers, copper cable high-speed connections, communication equipment, and computing power leasing, while retail, liquor, and grain sectors saw significant declines [2][6]. Important News - The Ministry of Commerce is intensifying efforts to implement a consumption upgrade policy, which includes a trade-in program for consumer goods. The spokesperson indicated that the economic fundamentals remain strong, and the consumption market is expected to continue stable growth next year. Key initiatives include promoting consumption activities, expanding service consumption, and fostering new types of consumption such as ice and snow economy, silver economy, and digital consumption [2][6]. - In November, China's new energy vehicle (NEV) production and sales continued to grow rapidly, reaching historical highs. Production and sales for November were 1.566 million and 1.512 million units respectively, marking year-on-year increases of 45.8% and 47.4%. From January to November, NEV production and sales totaled 11.345 million and 11.262 million units, with year-on-year growth of 34.6% and 35.6%. Domestic sales for the same period reached 10.121 million units, up 40.3% year-on-year, while exports were 1.141 million units, a 4.5% increase [2][6]. Industry Insights - Shenzhen has released measures to establish itself as a pioneer city in artificial intelligence (AI), aiming to create a national AI innovation development pilot zone. The measures include subsidies for computing power and large model applications, which are expected to significantly reduce costs for enterprises in AI model training and application [7][10]. - The measures also propose annual investments to support AI applications in urban governance and public services, as well as incentives for the development of AI hardware products. This is anticipated to accelerate the digital transformation of traditional industries and create substantial market growth opportunities in various application scenarios [10][11]. - The establishment of an AI industry fund is also highlighted, focusing on early-stage investments in hard technology, which is expected to support innovative enterprises with long-term development potential and promote a healthy cycle between technology, industry, and finance [10][11].

Investment Rating - The industry investment rating is "Outperform the Market" with an expected relative increase of over 10% in the industry index compared to the market over the next six months [12]. Core Insights - Shenzhen has issued measures to establish itself as a leading city in artificial intelligence, aiming to create a national AI innovation development pilot zone and an AI application leading area [1]. - The measures include substantial financial support for AI infrastructure and model applications, which are expected to significantly reduce costs for enterprises in training AI models and purchasing model services [2]. - The initiative also aims to support AI applications across various sectors, promoting digital transformation in traditional industries and fostering software innovation [3]. - The establishment of patient and bold capital is emphasized to support early-stage investments in hard technology, facilitating mergers and acquisitions to promote innovative enterprises [4]. Summary by Sections Investment Highlights - The measures propose annual subsidies for advanced computing infrastructure, including a maximum of 500 million yuan for "training vouchers" to lower AI model development costs, and 50 million yuan for "corpus vouchers" to promote data sharing [2]. - Support for AI applications in urban governance and public services, with funding for hardware products and software development, is also outlined [3]. Industry Outlook - The report suggests that the measures will create a more open application environment for AI, leading to significant market growth in various application scenarios [3]. - The focus on nurturing patient and bold capital is expected to drive high-quality development in the AI sector, supporting long-term growth and innovation [4]. Investment Recommendations - The report recommends focusing on companies in the computing infrastructure chain and high-quality enterprises in Shenzhen, as well as opportunities arising from AI applications and data element industries [9].

Core Viewpoints - The A-share market showed an upward trend on Wednesday, with the Shanghai Composite Index rising by 0.62%, the Shenzhen Component Index increasing by 0.44%, and the ChiNext Index slightly up by 0.04%. The total market turnover was 1.3753 trillion yuan, a decrease of 149.9 billion yuan from the previous day, with over 2800 stocks rising across the market [1][4]. Important News - The State-owned Assets Supervision and Administration Commission (SASAC) recently issued guidelines to improve the market value management of central enterprises. The guidelines include six areas for improvement: mergers and acquisitions, market-oriented reforms, information disclosure, investor relations management, investor returns, and stock buybacks. This new regulation is expected to enhance the activity of central enterprises in capital market mergers and acquisitions and support the recovery of market value for long-term undervalued central enterprises [1][4]. - The People's Bank of China and the State Administration of Foreign Exchange have optimized the pilot policies for multinational companies' integrated currency pool business. The new policies allow for cross-border payments using different currencies among domestic members of multinational companies, simplify the approval process for foreign-related payments, and support centralized payment management, thereby improving the efficiency of fund utilization [1][4].

Investment Rating - The report maintains an "Outperform" rating for the banking industry as of December 17, 2024 [2]. Core Insights - The banking sector showed a slight improvement in performance in the first three quarters of 2024, with a year-on-year revenue growth rate of -1.05% and a net profit growth rate of 1.4%, indicating a recovery trend [28][29]. - The overall performance for 2025 is expected to rebound, with stable growth anticipated in asset scale and a smaller decline in net interest margin compared to 2024 [2][110]. - The report emphasizes the importance of debt restructuring and capital injection in stabilizing the banking sector's quality and quantity [9][56]. Summary by Sections 1. Performance Review for Q1-Q3 2024 - The revenue growth rate for 42 listed banks was -1.05%, while net profit growth was 1.4%, showing a slight recovery compared to previous quarters [28]. - The expansion of asset scale and significant growth in non-interest income contributed positively, while net interest income and commission income continued to decline [29][30]. 2. Debt Restructuring and Capital Injection - The restructuring of hidden debts is expected to improve asset quality, with a projected reduction in interest income but a decrease in credit costs due to improved asset quality [49][54]. - Capital injections into state-owned banks are anticipated to stabilize growth and enhance risk resistance capabilities [56]. 3. Outlook for 2025 - The overall growth rate for 2025 is expected to stabilize at a low level, with a smaller decline in net interest margin compared to 2024 [110]. - Fee income is projected to stabilize as market conditions improve, and the contribution of provisions to profits is expected to decline [110][90]. 4. Investment Strategy - The banking sector has seen a significant increase in valuation, with the banking index rising 37.5% from January to December 2024, outperforming the broader market [111]. - The defensive attributes of the banking sector are highlighted, with high dividend strategies gaining traction amid a favorable macroeconomic environment [113].

[Table_Title] 万联晨会 [Table_MeetReportDate] 2024 年 12 月 18 日 星期三 [Table_Summary] 概览 核心观点 【市场回顾】周二 A 股三大指数下跌，截至收盘，上证综指跌 0.73%， 深成指跌 0.35%，创业板指跌 0.02%，全市场成交额 15252 亿元，较 上日减少 1917 亿元。全市场近 4800 只个股下跌。板块题材上，足球 概念、汽车整车、白酒板块涨幅排名靠前；教育、影视院线、大消费 方向跌幅较大。 【重要新闻】 【国务院国资委：着力提高上市公司发展质量】12 月 17 日，为进一 步推动中央企业高度重视控股上市公司市场价值表现，规范有序开展 市值管理工作，提升上市公司投资价值，切实维护投资者权益，以更 有力的行动举措促进资本市场健康稳定发展，国务院国资委近日印发 了《关于改进和加强中央企业控股上市公司市值管理工作的若干意 见》（以下简称《意见》）。《意见》指出，要着力提高上市公司发展质 量。中央企业要指导控股上市公司积极贯彻落实党中央、国务院关于 深化国资国企改革的重大部署，围绕国有经济布局优化和结构调整主 动作为，增强核心功能 ...

Investment Rating - The report initiates coverage with a "Buy" rating for the company Dacilin (大参林) [7][15]. Core Views - The company is a leading chain pharmacy in South China and ranks among the top in the country, with retail from directly operated stores being the main source of revenue and profit. The company has expanded its presence to 21 provinces through a combination of self-built stores, acquisitions, and franchises. Future growth is expected to come from enhancing the profitability and operational efficiency of stores outside its traditional regions [4][5]. Summary by Sections Company Overview - Dacilin has been established for 25 years and is the largest chain pharmacy in South China, focusing on both traditional Chinese and Western medicine, health products, and medical devices. The company has expanded its operations to cover 21 provinces, with significant market shares in Guangdong, Guangxi, Henan, and Heilongjiang. As of Q3 2024, the company operates 16,453 stores nationwide, leading the industry [12][53]. Market Opportunities - The trend of prescription drug outflow presents new opportunities for large chain pharmacies. The outpatient management of designated retail pharmacies is accelerating this trend, with significant growth potential in the outpatient market compared to Japan and the US. The aging population and the increasing reliance on insurance for chronic disease management further support this growth [5][14]. Expansion Strategy - The company employs a "self-built + acquisition + franchise" strategy to expand its market presence. The number of directly operated and franchise stores is increasing, with a focus on both strong and weak regions. The company has seen a shift towards franchise operations, particularly in regions outside its traditional stronghold [6][19][108]. Financial Forecast - The company forecasts revenues of 27.26 billion yuan in 2024, with a growth rate of 11.12%. The net profit attributable to shareholders is expected to be 1.02 billion yuan, reflecting a decrease of 12.63% compared to the previous year. The earnings per share (EPS) is projected to be 0.89 yuan for 2024, with a price-to-earnings (PE) ratio of 18.12 [5][15]. Investment Recommendations - The report suggests that Dacilin, as a leader in the pharmaceutical retail industry, is well-positioned to enhance its performance in provinces outside its traditional markets while maintaining its stronghold in South China. The company is expected to improve its overall profitability and management efficiency [15][24].